Effect of Toll-like Receptor 4 Deficiency on Clinical Severity and Expression of Th1/Th2/Th17-associated Cytokines in a Murine Model of Experimental Autoimmune Neuritis

Overview

Journal Arch Med Sci

Specialty General Medicine

Date 2023 Aug 10

PMID 37560732

Authors

Li-Juan Wang

Jie Zhu

Xiu-Juan Wu

Ting Li

Chun-Jiao Yang

Xi-Xiong Kang

Hong-Liang Zhang

Guo-Jun Zhang

Affiliations

Soon will be listed here.

Abstract

Introduction: The aim was to observe the effect of Toll-like receptor 4 (TLR4) deficiency on clinical severity and expression of Th1/Th2/Th17-associated cytokines in experimental autoimmune neuritis (EAN).

Material And Methods: We selected C57BL/10 wild type (WT) mice and TLR4 knockout (KO) mice with the C57BL/10 background for induction of the EAN model by immunizing mice twice (days 0 and 8) via subcutaneous injection of 180 μg P0 peptide 180-199 emulsion in 25 μl of PBS and 0.5 mg (Difco, USA) in 25 μl of Freund's incomplete adjuvant into the back of mice. The concentrations of serum cytokines (IL-2, IL-4, IL-6, IL-10, IL-17A, IFN-γ and TNF) were determined using the Ms Th1/Th2/Th17 CBA kit.

Results: We found that TLR4 deficiency could attenuate the clinical severity and delay the onset of EAN. Moreover, our data showed that the sera levels of IFN-γ, TNF, IL-6 and IL-17A were elevated in the WT mice with EAN when compared with the naive WT mice, but only the production of IL-17A was significantly lower in the TLR4 KO mice with EAN than in their WT counterparts.

Conclusions: Based on these findings, TLR4 may contribute to the pathogenesis of EAN by regulating Th17 cells and the production of Th17-associated factors. However, the exact mechanism remains unclear and more evidence is needed to elucidate its role in EAN.

References

Yuki N, Hartung H . Guillain-Barré syndrome. N Engl J Med. 2012; 366(24):2294-304. DOI: 10.1056/NEJMra1114525. View

Banus S, Stenger R, Gremmer E, Dormans J, Mooi F, Kimman T . The role of Toll-like receptor-4 in pertussis vaccine-induced immunity. BMC Immunol. 2008; 9:21. PMC: 2409298. DOI: 10.1186/1471-2172-9-21. View

Bhan U, Ballinger M, Zeng X, Newstead M, Cornicelli M, Standiford T . Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17 production in a murine model of gram negative bacterial pneumonia. PLoS One. 2010; 5(3):e9896. PMC: 2845620. DOI: 10.1371/journal.pone.0009896. View

Li H, Li X, Zhang M, Xu H, Wang C, Wang S . Berberine ameliorates experimental autoimmune neuritis by suppressing both cellular and humoral immunity. Scand J Immunol. 2013; 79(1):12-9. DOI: 10.1111/sji.12123. View

Wang Q, Yang H, Liu H, Mi S, Zhang X, Yan H . Interleukin-17A is involved in development of spontaneous pulmonary emphysema caused by Toll-like receptor 4 mutation. Acta Pharmacol Sin. 2011; 32(8):1045-54. PMC: 4002530. DOI: 10.1038/aps.2011.67. View

Reynolds J, Pappu B, Peng J, Martinez G, Zhang Y, Chung Y . Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity. 2010; 32(5):692-702. PMC: 2878917. DOI: 10.1016/j.immuni.2010.04.010. View

Deng Y, Zhou W . Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis. Neuroimmunomodulation. 2008; 14(6):337-43. DOI: 10.1159/000127433. View

Brunn A, Mihelcic M, Carstov M, Feind L, Wieser E, Schmidt J . Toll-Like Receptor 2, Toll-Like Receptor 4, Myeloid Differentiation Response Gene 88, and Toll-IL-1 Receptor Domain-Containing Adaptor-Inducing Interferon-γ (TRIF) Selectively Regulate Susceptibility of P0-Induced Murine Experimental Autoimmune.... Am J Pathol. 2016; 187(1):42-54. DOI: 10.1016/j.ajpath.2016.09.009. View

Wang Y, Liang Q, Ramkalawan H, Wang Y, Yang Y, Zhou W . Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barré syndrome. Neuroimmunomodulation. 2011; 19(1):60-8. DOI: 10.1159/000328200. View

10.

Wang X, Ma C, Wu J, Zhu J . Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models. J Neurosci Res. 2013; 91(7):871-81. DOI: 10.1002/jnr.23233. View

11.

Zhang H, Azimullah S, Zheng X, Wang X, Amir N, Mensah-Brown E . IFN-γ deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response. J Neuroimmunol. 2012; 246(1-2):18-26. DOI: 10.1016/j.jneuroim.2012.02.011. View

12.

Mu H, Hasebe A, Van Schelt A, Cole B . Novel interactions of a microbial superantigen with TLR2 and TLR4 differentially regulate IL-17 and Th17-associated cytokines. Cell Microbiol. 2010; 13(3):374-87. DOI: 10.1111/j.1462-5822.2010.01540.x. View

13.

ONeill L . When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity. 2008; 29(1):12-20. DOI: 10.1016/j.immuni.2008.06.004. View

14.

Liang S, Wang W, Huang S, Wang X, Zhang S, Wu Y . Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barré syndrome. Immunopharmacol Immunotoxicol. 2012; 34(6):1039-46. DOI: 10.3109/08923973.2012.697469. View

15.

Gries M, Davies L, Liu Y, Bachhuber A, Spiegel J, Dillmann U . Response of Toll-like receptors in experimental Guillain-Barré syndrome: a kinetic analysis. Neurosci Lett. 2012; 518(2):154-60. DOI: 10.1016/j.neulet.2012.04.077. View

16.

Li S, Jin T, Zhang H, Yu H, Meng F, Quezada H . Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Mediators Inflamm. 2014; 2014:740947. PMC: 4036596. DOI: 10.1155/2014/740947. View

17.

Du Y, Zhang G, Zhang Z, Wang Q, Ma R, Zhang L . Toll-like receptor 2 and -4 are involved in the pathogenesis of the Guillain-Barré syndrome. Mol Med Rep. 2015; 12(2):3207-13. DOI: 10.3892/mmr.2015.3730. View

18.

Zhang Z, Zhang Z, Schluesener H . FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis. Neuropathol Appl Neurobiol. 2009; 35(5):487-95. DOI: 10.1111/j.1365-2990.2009.01016.x. View

19.

Zhang H, Zheng X, Zhu J . Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev. 2013; 24(5):443-53. DOI: 10.1016/j.cytogfr.2013.05.005. View

20.

Goodfellow J, Willison H . Guillain-Barré syndrome: a century of progress. Nat Rev Neurol. 2016; 12(12):723-731. DOI: 10.1038/nrneurol.2016.172. View